Selected research
Industry Research
Diltiazem Industry Research Report 2026
Market perspective
The global Diltiazem market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Diltiazem is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Diltiazem is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Diltiazem is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Diltiazem include Akorn, Athenex, Bausch Health, Hikma Pharmaceuticals, Par Pharmaceutical, Zydus Pharmaceuticals, Pfizer, Mylan and Sandoz, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Diltiazem market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Diltiazem Market by Company
Akorn
Athenex
Bausch Health
Hikma Pharmaceuticals
Par Pharmaceutical
Zydus Pharmaceuticals
Pfizer
Mylan
Sandoz
Sun Pharma
Teva
Diltiazem Segment by Type
Injection
Tablet
Capsule
Diltiazem Segment by Application
Angina
Hypertension
Diltiazem Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diltiazem market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diltiazem and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diltiazem.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Diltiazem manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Diltiazem by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Diltiazem in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Tablet
- Capsule
Applications
- Angina
- Hypertension
Companies covered
- Akorn
- Athenex
- Bausch Health
- Hikma Pharmaceuticals
- Par Pharmaceutical
- Zydus Pharmaceuticals
- Pfizer
- Mylan
- Sandoz
- Sun Pharma
- Teva
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Diltiazem Market Size (2021-2032)
- 2.2.2 Global Diltiazem Sales (2021-2032)
- 2.2.3 Global Diltiazem Market Average Price (2021-2032)
- 2.3 Diltiazem by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injection
- 2.3.3 Tablet
- 2.3.4 Capsule
- 2.4 Diltiazem by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Angina
- 2.4.3 Hypertension
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Diltiazem Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Diltiazem Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Diltiazem Revenue of Manufacturers (2021-2026)
- 3.4 Global Diltiazem Average Price by Manufacturers (2021-2026)
- 3.5 Global Diltiazem Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Diltiazem, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Diltiazem, Product Type & Application
- 3.8 Global Manufacturers of Diltiazem, Established Date
- 3.9 Global Diltiazem Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Akorn
- 4.1.1 Akorn Company Information
- 4.1.2 Akorn Business Overview
- 4.1.3 Akorn Diltiazem Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Akorn Diltiazem Product Portfolio
- 4.1.5 Akorn Recent Developments
- 4.2 Athenex
- 4.2.1 Athenex Company Information
- 4.2.2 Athenex Business Overview
- 4.2.3 Athenex Diltiazem Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Athenex Diltiazem Product Portfolio
- 4.2.5 Athenex Recent Developments
- 4.3 Bausch Health
- 4.3.1 Bausch Health Company Information
- 4.3.2 Bausch Health Business Overview
- 4.3.3 Bausch Health Diltiazem Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bausch Health Diltiazem Product Portfolio
- 4.3.5 Bausch Health Recent Developments
- 4.4 Hikma Pharmaceuticals
- 4.4.1 Hikma Pharmaceuticals Company Information
- 4.4.2 Hikma Pharmaceuticals Business Overview
- 4.4.3 Hikma Pharmaceuticals Diltiazem Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hikma Pharmaceuticals Diltiazem Product Portfolio
- 4.4.5 Hikma Pharmaceuticals Recent Developments
- 4.5 Par Pharmaceutical
- 4.5.1 Par Pharmaceutical Company Information
- 4.5.2 Par Pharmaceutical Business Overview
- 4.5.3 Par Pharmaceutical Diltiazem Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Par Pharmaceutical Diltiazem Product Portfolio
- 4.5.5 Par Pharmaceutical Recent Developments
- 4.6 Zydus Pharmaceuticals
- 4.6.1 Zydus Pharmaceuticals Company Information
- 4.6.2 Zydus Pharmaceuticals Business Overview
- 4.6.3 Zydus Pharmaceuticals Diltiazem Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Zydus Pharmaceuticals Diltiazem Product Portfolio
- 4.6.5 Zydus Pharmaceuticals Recent Developments
- 4.7 Pfizer
- 4.7.1 Pfizer Company Information
- 4.7.2 Pfizer Business Overview
- 4.7.3 Pfizer Diltiazem Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Pfizer Diltiazem Product Portfolio
- 4.7.5 Pfizer Recent Developments
- 4.8 Mylan
- 4.8.1 Mylan Company Information
- 4.8.2 Mylan Business Overview
- 4.8.3 Mylan Diltiazem Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Mylan Diltiazem Product Portfolio
- 4.8.5 Mylan Recent Developments
- 4.9 Sandoz
- 4.9.1 Sandoz Company Information
- 4.9.2 Sandoz Business Overview
- 4.9.3 Sandoz Diltiazem Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sandoz Diltiazem Product Portfolio
- 4.9.5 Sandoz Recent Developments
- 4.10 Sun Pharma
- 4.10.1 Sun Pharma Company Information
- 4.10.2 Sun Pharma Business Overview
- 4.10.3 Sun Pharma Diltiazem Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Sun Pharma Diltiazem Product Portfolio
- 4.10.5 Sun Pharma Recent Developments
- 4.11 Teva
- 4.11.1 Teva Company Information
- 4.11.2 Teva Business Overview
- 4.11.3 Teva Diltiazem Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Teva Diltiazem Product Portfolio
- 4.11.5 Teva Recent Developments
5 Global Diltiazem Market Scenario by Region
- 5.1 Global Diltiazem Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Diltiazem Sales by Region: 2021-2032
- 5.2.1 Global Diltiazem Sales by Region: 2021-2026
- 5.2.2 Global Diltiazem Sales by Region: 2027-2032
- 5.3 Global Diltiazem Revenue by Region: 2021-2032
- 5.3.1 Global Diltiazem Revenue by Region: 2021-2026
- 5.3.2 Global Diltiazem Revenue by Region: 2027-2032
- 5.4 North America Diltiazem Market Facts & Figures by Country
- 5.4.1 North America Diltiazem Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Diltiazem Sales by Country (2021-2032)
- 5.4.3 North America Diltiazem Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Diltiazem Market Facts & Figures by Country
- 5.5.1 Europe Diltiazem Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Diltiazem Sales by Country (2021-2032)
- 5.5.3 Europe Diltiazem Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Diltiazem Market Facts & Figures by Country
- 5.6.1 Asia Pacific Diltiazem Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Diltiazem Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Diltiazem Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Diltiazem Market Facts & Figures by Country
- 5.7.1 South America Diltiazem Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Diltiazem Sales by Country (2021-2032)
- 5.7.3 South America Diltiazem Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Diltiazem Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Diltiazem Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Diltiazem Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Diltiazem Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Diltiazem Sales by Type (2021-2032)
- 6.1.1 Global Diltiazem Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Diltiazem Sales Market Share by Type (2021-2032)
- 6.2 Global Diltiazem Revenue by Type (2021-2032)
- 6.2.1 Global Diltiazem Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Diltiazem Revenue Market Share by Type (2021-2032)
- 6.3 Global Diltiazem Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Diltiazem Sales by Application (2021-2032)
- 7.1.1 Global Diltiazem Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Diltiazem Sales Market Share by Application (2021-2032)
- 7.2 Global Diltiazem Revenue by Application (2021-2032)
- 7.2.1 Global Diltiazem Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Diltiazem Revenue Market Share by Application (2021-2032)
- 7.3 Global Diltiazem Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Diltiazem Value Chain Analysis
- 8.1.1 Diltiazem Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Diltiazem Production Mode & Process
- 8.2 Diltiazem Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Diltiazem Distributors
- 8.2.3 Diltiazem Customers
9 Global Diltiazem Analyzing Market Dynamics
- 9.1 Diltiazem Industry Trends
- 9.2 Diltiazem Industry Drivers
- 9.3 Diltiazem Industry Opportunities and Challenges
- 9.4 Diltiazem Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst